Zobrazeno 1 - 10
of 27
pro vyhledávání: '"I. V. SCHASTLIVTSEV"'
Autor:
S. Yu. Martsevich S.Yu., A. R. Navasardyan, K. V. Lobastov, M. V. Mikaelyan, E. V. Mikhaylenko, A. Yu. Suvorov, I. V. Schastlivtsev, O. N. Dzhioeva, V. V. Matveev, E. S. Akimova, V. V. Sytkov, E. Dubar, O. M. Drapkina
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 19, Iss 4, Pp 382-397 (2023)
Nowadays, the pyramid of evidence is the main model of decision-making for healthcare professionals. According to this concept, data from randomized clinical trials (RCTs) are considered lower in hierarchy than data obtained from systematic reviews (
Externí odkaz:
https://doaj.org/article/0cbcda50d7d54cd38b6ce975ce7ef017
Autor:
K. V. Lobastov, M. V. Shaldina, D. A. Borsuk, I. V. Schastlivtsev, L. A. Laberko, А. A. Fokin
Publikováno v:
Амбулаторная хирургия, Vol 19, Iss 2, Pp 62-71 (2022)
Venous thromboembolic complications (VTEO) after modern minimally invasive superficial vein interventions are an infrequent but very dramatic event. This article presents a review of the literature, covering the issues of prevalence, prognosis and ph
Externí odkaz:
https://doaj.org/article/19c59f6cfd704270938e8cbfae3d817e
Autor:
O. Ya. Porembskaya, V. N. Kravchuk, M. I. Galchenko, R. V. Deev, M. Sh. Chesnokov, A. V. Avanesyan, K. V. Lobastov, S. N. Tsaplin, L. A. Laberko, V. S. Ermakov, O. V. Pashovkina, I. V. Schastlivtsev, S. A. Sayganov
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 18, Iss 4, Pp 376-384 (2022)
Aim. We aimed to study the histological and thrombotic changes in lung vessels in patients who died with COVID-19, to access the correlation between anticoagulation therapy (ACT) and thrombotic events (TE), treatment results, clinical and laboratory
Externí odkaz:
https://doaj.org/article/99acba87ea4c4f0b9d67721093498754
Publikováno v:
Амбулаторная хирургия, Vol 18, Iss 2, Pp 17-30 (2021)
The article is a non-systematic review of the literature, addressing the effectiveness, safety and appropriateness of antithrombotic drugs for COVID-19 in patients undergoing treatment in different settings: in the hospital phase, including the inten
Externí odkaz:
https://doaj.org/article/ae7a711458d946579385bf87221ac82f
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 17, Iss 3, Pp 376-385 (2021)
Aim. To assess the duration of the anticoagulant treatment of venous thromboembolism (VTE) in various categories of patients in real clinical practice through survey of practitioners, as well as correspondence of the duration with current clinical gu
Externí odkaz:
https://doaj.org/article/a55ba126786b461a8e33d8c089441776
Autor:
K. V. Lobastov, I. V. Schastlivtsev, O. Ya. Porembskaya, O. V. Dzenina, A. B. Bargandzhiya, S. N. Tsaplin
Publikováno v:
Амбулаторная хирургия, Vol 0, Iss 3-4, Pp 36-51 (2021)
The coronavirus infection COVID-19 is a highly contagious disease caused by the SARS-CoV-2 virus. Specific prothrombotic changes of the hemostasis system in COVID-19 are associated with increased incidence of venous thromboembolic complications. The
Externí odkaz:
https://doaj.org/article/e430902fdb7c4eb89e3464c0b925a154
Autor:
К. V. Lobastov, I. V. Schastlivtsev
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 16, Iss 2, Pp 286-295 (2020)
This article is a review of epidemiology, pathogenesis and treatment of venous thromboembolism (VTE) in cancer patients. In accordance with actual guidelines, the duration of anticoagulant therapy of cancer-related venous thrombosis should be at leas
Externí odkaz:
https://doaj.org/article/7e62dbf3e4bb4320b6c7fb3c07c1d2db
Publikováno v:
Медицинский совет, Vol 0, Iss 16, Pp 72-77 (2019)
For many years, there has been no model capable of explaining the complex processes of interaction between various bloodclotting factors leading to a stop of bleeding. One of the most successful models able to partially reflect the mechanisms of hemo
Externí odkaz:
https://doaj.org/article/293999eef86c4307b89f0ea44bf55b77
Autor:
I. V. SCHASTLIVTSEV, K. V. LOBASTOV, V. E. BARINOV, S. N. TSAPLIN, A. V. VORONTSOVA, L. A. LABERKO, G. V. RODOMAN, V. V. BOYARINTSEV
Publikováno v:
Медицинский совет, Vol 0, Iss 10, Pp 112-118 (2016)
Study objective: to evaluate safety of prolonged therapy of venous thrombosis by rivarixaban compared to the standard scheme of therapy by low-molecular heparins (LMH) with subsequent transfer to warfarin administration. Materials and methods. Prospe
Externí odkaz:
https://doaj.org/article/7882e9cc73ee48629bf6b33e1cc330cc
Publikováno v:
Medical alphabet. :45-49
Heparin-induced thrombocytopenia (GIT) is a paradoxical reaction of platelets to heparin (their aggregation and destruction), potentially dangerous by the development of venous and arterial thrombosis, less often bleeding. There are serious problems
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::47bfe5f6234a4977a01d5fb780b92174
https://doi.org/10.33667/2078-5631-2022-25-45-49
https://doi.org/10.33667/2078-5631-2022-25-45-49